Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Amortization - Intangibles (2016 - 2019)

Plus Therapeutics (PSTV) has disclosed Amortization - Intangibles for 4 consecutive years, with $306000.0 as the latest value for Q1 2019.

  • Quarterly Amortization - Intangibles changed 0.0% to $306000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2019, changed 0.0% year-over-year, with the annual reading at $1.2 million for FY2018, 0.0% changed from the prior year.
  • Amortization - Intangibles for Q1 2019 was $306000.0 at Plus Therapeutics, roughly flat from $306000.0 in the prior quarter.
  • The five-year high for Amortization - Intangibles was $308000.0 in Q4 2016, with the low at $57000.0 in Q3 2016.
  • Average Amortization - Intangibles over 4 years is $253846.2, with a median of $306000.0 recorded in 2017.
  • Peak annual rise in Amortization - Intangibles hit 436.84% in 2017, while the deepest fall reached 0.65% in 2017.
  • Over 4 years, Amortization - Intangibles stood at $308000.0 in 2016, then fell by 0.65% to $306000.0 in 2017, then changed by 0.0% to $306000.0 in 2018, then changed by 0.0% to $306000.0 in 2019.
  • According to Business Quant data, Amortization - Intangibles over the past three periods came in at $306000.0, $306000.0, and $306000.0 for Q1 2019, Q4 2018, and Q3 2018 respectively.